BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 28637869)

  • 1. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
    Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
    J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
    Nair S; Zlotnick A
    J Virol; 2018 May; 92(10):. PubMed ID: 29491156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C.
    Baumert TF; Rösler C; Malim MH; von Weizsäcker F
    Hepatology; 2007 Sep; 46(3):682-9. PubMed ID: 17625792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication.
    Bonvin M; Achermann F; Greeve I; Stroka D; Keogh A; Inderbitzin D; Candinas D; Sommer P; Wain-Hobson S; Vartanian JP; Greeve J
    Hepatology; 2006 Jun; 43(6):1364-74. PubMed ID: 16729314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.
    Suspène R; Guétard D; Henry M; Sommer P; Wain-Hobson S; Vartanian JP
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8321-6. PubMed ID: 15919829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.
    Vartanian JP; Henry M; Marchio A; Suspène R; Aynaud MM; Guétard D; Cervantes-Gonzalez M; Battiston C; Mazzaferro V; Pineau P; Dejean A; Wain-Hobson S
    PLoS Pathog; 2010 May; 6(5):e1000928. PubMed ID: 20523896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β triggers HBV cccDNA degradation through AID-dependent deamination.
    Qiao Y; Han X; Guan G; Wu N; Sun J; Pak V; Liang G
    FEBS Lett; 2016 Feb; 590(3):419-27. PubMed ID: 26867650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA mutagenic activity and capacity for HIV-1 restriction of the cytidine deaminase APOBEC3G depend on whether DNA or RNA binds to tyrosine 315.
    Polevoda B; Joseph R; Friedman AE; Bennett RP; Greiner R; De Zoysa T; Stewart RA; Smith HC
    J Biol Chem; 2017 May; 292(21):8642-8656. PubMed ID: 28381554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
    He X; Li J; Wu J; Zhang M; Gao P
    Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G.
    Nguyen DH; Gummuluru S; Hu J
    J Virol; 2007 May; 81(9):4465-72. PubMed ID: 17314171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.
    Jost S; Turelli P; Mangeat B; Protzer U; Trono D
    J Virol; 2007 Oct; 81(19):10588-96. PubMed ID: 17652382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
    Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
    World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA.
    Kitamura K; Wang Z; Chowdhury S; Simadu M; Koura M; Muramatsu M
    PLoS Pathog; 2013; 9(5):e1003361. PubMed ID: 23696735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human-APOBEC3G-dependent restriction of porcine endogenous retrovirus replication is mediated by cytidine deamination and inhibition of DNA strand transfer during reverse transcription.
    Jin SY; Choi HY; Kim HS; Jung YT
    Arch Virol; 2018 Jul; 163(7):1907-1914. PubMed ID: 29610985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database.
    Lindley RA; Hall NE
    Mutat Res; 2018 Jul; 810():33-38. PubMed ID: 29957488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compound IMB-Z inhibits hepatitis B virus replication through increasing APOBEC3G expression and incorporation into viral nucleocapsids.
    Hu J; Wang H; Yang L; Wu S; Li Y; Li Y; Li Z
    J Glob Antimicrob Resist; 2022 Dec; 31():371-378. PubMed ID: 36396043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A3G-induced mutations show a low prevalence and exhibit plus-strand regional distribution in hepatitis B virus DNA from patients with non-hepatocellular carcinoma (HCC) and HCC.
    Ren F; Li W; Zhao S; Wang L; Wang Q; Li M; Xiang A; Guo Y
    J Med Virol; 2021 Jun; 93(6):3672-3678. PubMed ID: 32779759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOBEC3DE Antagonizes Hepatitis B Virus Restriction Factors APOBEC3F and APOBEC3G.
    Bouzidi MS; Caval V; Suspène R; Hallez C; Pineau P; Wain-Hobson S; Vartanian JP
    J Mol Biol; 2016 Aug; 428(17):3514-28. PubMed ID: 27289067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G.
    Henry M; Guétard D; Suspène R; Rusniok C; Wain-Hobson S; Vartanian JP
    PLoS One; 2009; 4(1):e4277. PubMed ID: 19169351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concerted action of activation-induced cytidine deaminase and uracil-DNA glycosylase reduces covalently closed circular DNA of duck hepatitis B virus.
    Chowdhury S; Kitamura K; Simadu M; Koura M; Muramatsu M
    FEBS Lett; 2013 Sep; 587(18):3148-52. PubMed ID: 23954625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.